Trends and Disparities in Mortality Related to Aortic Aneurysm and Aortic Dissection in the United States (1999-2023): An Analysis Using the CDC WONDER Database - Scorecard - MDSpire
Advertisement
Trends and Disparities in Mortality Related to Aortic Aneurysm and Aortic Dissection in the United States (1999-2023): An Analysis Using the CDC WONDER Database
Clinical Scorecard: Trends and Disparities in Mortality Related to Aortic Aneurysm and Aortic Dissection in the United States (1999-2023): An Analysis Using the CDC WONDER Database
At a Glance
Category
Detail
Condition
Aortic aneurysm (AA) and aortic dissection (AD)
Key Mechanisms
AA involves localized aortic dilation due to medial layer impairment; AD involves intimal tear creating a false lumen in the aortic media
Target Population
Adults aged ≥ 25 years in the United States
Care Setting
Hospital and outpatient settings including surgical and endovascular interventions
Key Highlights
AA classified into thoracic (TAA) and abdominal (AAA) subtypes; AD classified by Stanford types A and B with differing prognosis and management
AA mortality in the US has declined overall, but TAA incidence has increased; AD incidence stable with reduced in-hospital mortality for type A
Significant disparities in mortality exist by sex, race/ethnicity, age, geographic region, and urbanization status
Guideline-Based Recommendations
Diagnosis
Use imaging modalities (e.g., chest imaging) for detection of TAA and AAA
Classify AD by Stanford system to guide management
Management
Conservative pharmacotherapy (β-blockers, statins) for low-risk unruptured AA (diameter <5 cm, asymptomatic)
Open surgical repair for ruptured AA and acute type A AD requiring urgent intervention
Endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) favored for ruptured AA, elderly patients, and complicated type B AD
Microsurgical clipping for complex aneurysms in selected younger patients
Optimal medical therapy for uncomplicated type B AD
Monitoring & Follow-up
Regular imaging surveillance for aneurysm size and progression
Monitor blood pressure and cardiovascular risk factors to prevent AD and AA progression
Risks
Hypertension, aging, smoking, atherosclerosis, obesity, and substance abuse increase risk
Delayed diagnosis and inadequate treatment contribute to higher mortality, especially in developing regions and disadvantaged populations
Patient & Prescribing Data
Adults ≥ 25 years with AA or AD in the United States
Pharmacotherapy with β-blockers and statins reduces rupture risk in low-risk AA; surgical and endovascular interventions tailored by disease type and patient factors
Clinical Best Practices
Early identification and risk stratification using imaging and clinical classification systems
Tailor management strategies based on aneurysm size, rupture status, dissection type, and patient comorbidities
Address disparities by improving healthcare access and targeted interventions in high-risk demographic groups
Implement preventive measures including smoking cessation and hypertension control
Utilize multidisciplinary approaches combining medical, surgical, and endovascular therapies